Bioretec (FRA:0TN) Debt-to-EBITDA : -0.40 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Bioretec Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Bioretec's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €1.30 Mil. Bioretec's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €0.43 Mil. Bioretec's annualized EBITDA for the quarter that ended in Dec. 2024 was €-4.38 Mil. Bioretec's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was -0.40.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Bioretec's Debt-to-EBITDA or its related term are showing as below:

FRA:0TN' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.39 Med: -0.79 Max: -0.34
Current: -0.43

During the past 7 years, the highest Debt-to-EBITDA Ratio of Bioretec was -0.34. The lowest was -1.39. And the median was -0.79.

FRA:0TN's Debt-to-EBITDA is ranked worse than
100% of 440 companies
in the Medical Devices & Instruments industry
Industry Median: 1.425 vs FRA:0TN: -0.43

Bioretec Debt-to-EBITDA Historical Data

The historical data trend for Bioretec's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioretec Debt-to-EBITDA Chart

Bioretec Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-EBITDA

Get a 7-Day Free Trial

-1.16

-0.79

-0.34

-0.37

-0.43

Bioretec Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Debt-to-EBITDA	Get a 7-Day Free Trial							-0.39	-0.74	-0.31	-0.50	-0.40

Competitive Comparison of Bioretec's Debt-to-EBITDA

For the Medical Devices subindustry, Bioretec's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioretec's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioretec's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bioretec's Debt-to-EBITDA falls into.

Save Embed

;

Save Embed

;

Bioretec Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Bioretec's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1.302	+	0.434)	/	-4.053
	=	-0.43

Bioretec's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1.302	+	0.434)	/	-4.38
	=	-0.40

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2024) EBITDA data.

Bioretec (FRA:0TN) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Bioretec Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bioretec's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioretec Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioretec Ltd (FRA:0TN) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

BRETEC:Finland

Address

Yrittajankulma 5, Tampere, FIN, FI-33710

Website

https://www.bioretec.com

Bioretec Ltd is a medical device company focusing on the development of safe, and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. The company's products are used world wide and continue to further develop materials and products for high-load-bearing clinical applications. Some of its brands include RemeOs, Activa IM-N, ActivaPi, and ActivaScrew.

Bioretec Headlines

No Headlines